This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Kenneth H. Kraemer, MD; Meenhard Herlyn, DVM; Stuart H. Yuspa, MD; Wallace H. Clark, Jr, MD; G. Kevin Townsend, MS; Gabrielle R. Neises; Vincent J. Hearing, PhD

Arch Dermatol. 1989;125(2):263-268.

Abstract
• Patients with xeroderma pigmentosum (XP) have more than a 1000-fold increased risk of cutaneous melanoma. To determine if the XP DNA repair defect is present in cutaneous pigmentary cells, nevus cells and melanocytes from four large, pigmented nevi were cultured from a 12-year-old girl with XP. Cultured melanocytes showed dendritic morphologic features, contained mature melanosomes, and reacted with monoclonal antibody to tyrosinase. Nevus cells were spindle shaped and expressed nevus cell—associated antigens. Melanocytes, nevus cells, and dermal fibroblasts from the patient with XP all had a similar reduction in DNA repair: unscheduled DNA synthesis was 30% to 50% of that in normal fibroblasts following a 30 J/m² ultraviolet dose. After a 6 J/m2 ultraviolet dose, the proliferative ability of XP nevus cells and fibroblasts was reduced to 10% of that of normal fibroblasts. This study indicates that cultured melanocytes and nevus cells express the characteristic XP DNA repair defect.

(Arch Dermatol 1989;125:263-268)

Author Affiliations
From the Laboratory of Molecular Carcinogenesis (Dr Kraemer and Mr Townsend), the Laboratory of Cellular Carcinogenesis and Tumor Promotion (Dr Yuspa), the Dermatology Branch (Ms Neises), the Laboratory of Cell Biology (Dr Hearing), National Cancer Institute, Bethesda, Md; the Wistar Institute (Dr Herlyn), and the Department of Dermatology, Hospital of the University of Pennsylvania (Dr Clark), Philadelphia. Ms Neises is now with Monsanto Physical Sciences Center, St Louis.

Footnotes
Accepted for publication July 25, 1988.

Reprint requests to Laboratory of Molecular Carcinogenesis, National Cancer Institute, Bldg 37, Room 3E24, Bethesda, MD 20892 (Dr Kraemer).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Impaired Processing of DNA Photoproducts and Ultraviolet Hypermutability With Loss of p16INK4a or p19ARF
Sarkar-Agrawal et al.
JNCI J Natl Cancer Inst 2004;96:1790-1793.
ABSTRACT | FULL TEXT  

Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene
Taylor et al.
Proc. Natl. Acad. Sci. USA 1997;94:8658-8663.
ABSTRACT | FULL TEXT  

Clearing of Melanoma In Situ With Intralesional Interferon Alfa in a Patient With Xeroderma Pigmentosum
Turner et al.
Arch Dermatol 1994;130:1491-1494.
ABSTRACT